We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
-13.79%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$60.7B
AUM Growth
-$3.86B
Cap. Flow
+$5.72B
Cap. Flow %
9.42%
Top 10 Hldgs %
45.78%
Holding
2,623
New
243
Increased
1,351
Reduced
530
Closed
342

Sector Composition

Rank Sector Weight
1 Technology 4.52%
2 Financials 3.01%
3 Healthcare 1.66%
4 Consumer Discretionary 1.56%
5 Consumer Staples 1.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSTR icon
2051
CALL
Strategy Inc
MSTR
$33.5B
$51K ﹤0.01%
+7,000
New +$202K
BBD icon
2052
Banco Bradesco
BBD
$38.1B
$50K ﹤0.01%
15,319
+2,111
+16% +$8.11K
PPT
2053
Franklin Premier Income Trust
PPT
$323M
$50K ﹤0.01%
13,027
DMK
2054
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$50K ﹤0.01%
1,429
+215
+18% +$6.71K
CNF
2055
CNFinance Holdings
CNF
$40.3M
$49K ﹤0.01%
+1,932
New +$54.8K
MMT
2056
Aberdeen Multi-Market Income Fund
MMT
$237M
$48K ﹤0.01%
10,452
+313
+3% +$1.51K
SSKN
2057
DELISTED
Strata Skin Sciences
SSKN
$48K ﹤0.01%
5,001
CRON
2058
Cronos Group
CRON
$1.05B
$47K ﹤0.01%
16,549
+3,100
+23% +$9.66K
GGN
2059
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$767M
$47K ﹤0.01%
13,019
+561
+5% +$2.2K
TRHC
2060
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$47K ﹤0.01%
+18,360
New +$68.9K
SID icon
2061
Companhia Siderúrgica Nacional
SID
$1.43B
$46K ﹤0.01%
15,602
+14,663
+1,562% +$61.8K
HMY icon
2062
Harmony Gold Mining
HMY
$9.92B
$45K ﹤0.01%
14,238
+584
+4% +$2.25K
POWW icon
2063
Outdoor Holding Co
POWW
$239M
$45K ﹤0.01%
11,668
+310
+3% +$1.29K
QCOM icon
2064
PUT
Qualcomm
QCOM
$176B
$45K ﹤0.01%
4,500
+100
+2% +$13.6K
EAR
2065
DELISTED
Eargo, Inc. Common Stock
EAR
$45K ﹤0.01%
2,981
BTMD icon
2066
Biote Corp
BTMD
$69.2M
$44K ﹤0.01%
+11,599
New +$91.1K
DERM icon
2067
Journey Medical
DERM
$170M
$44K ﹤0.01%
+11,764
New +$46.5K
ONCT
2068
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$44K ﹤0.01%
1,972
+6
+0.3% +$134
ABFL
2069
Abacus FCF Leaders ETF
ABFL
$527M
$43K ﹤0.01%
+946
New +$45.6K
LCTX icon
2070
Lineage Cell Therapeutics
LCTX
$257M
$42K ﹤0.01%
26,302
+721
+3% +$951
MIN
2071
Aberdeen Intermediate Income Fund
MIN
$273M
$42K ﹤0.01%
+14,102
New +$42.4K
SER icon
2072
Serina Therapeutics
SER
$31M
$42K ﹤0.01%
2,057
+568
+38% +$15.3K
ATAI icon
2073
AtaiBeckley Inc
ATAI
$2.66B
$41K ﹤0.01%
11,212
-1,910
-15% -$7.81K
GEVO icon
2074
Gevo
GEVO
$397M
$41K ﹤0.01%
17,627
+4,400
+33% +$16.1K
INTC icon
2075
CALL
Intel
INTC
$466B
$41K ﹤0.01%
7,300
+4,800
+192% +$208K

Similar funds

Creative Planning's Q2 2022 Portfolio in Review

As of Q2 2022, Creative Planning held 2,623 positions worth $60.7B, down 6% from $64.6B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Creative Planning deployed $5.72B of net new capital in Q2 2022, opening 243 new positions and adding to 1,351 existing holdings. Its largest new stake was Dimensional US Marketwide Value ETF: 2,518,817 shares worth $79.6M.

By sector, the portfolio is most concentrated in Technology at 4.5% of assets, down from 4.8% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard Total Bond Market, an estimated $379M trimmed.

  • Creative Planning's largest Q2 2022 buy was Dimensional US Marketwide Value ETF: 2,518,817 shares worth $79.6M.
  • Creative Planning added most to iShares Core S&P 500 ETF in Q2 2022, an estimated $1B increase.
  • Creative Planning's biggest Q2 2022 reduction was Vanguard Total Bond Market, cutting an estimated $379M.
  • Creative Planning fully exited CVB Financial in Q2 2022, selling an estimated $27.2M.
  • Creative Planning's ten largest holdings make up 46% of its $60.7B portfolio in Q2 2022.
  • Creative Planning opened 243 new positions and closed 342 in Q2 2022.
  • Creative Planning's portfolio value fell 6% quarter-over-quarter to $60.7B.

Based on Creative Planning's 13F filing for Q2 2022, filed 15 Aug 2022.